More News
13 March 2019
Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca13 March 2019
Flow Pharma, Inc. and OncoImmunity AS partner for the Development of FlowVaxTM Personalized Cancer Vaccines13 March 2019
HitGen and SPARC Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration11 March 2019
Parkinson’s disease: Servier and Oncodesign join forces to investigate new line of research11 March 2019
Stemline In-Licenses Worldwide Rights to Novel Selective RET Inhibitor (SL-1001); Expands Oncology Pipeline11 March 2019
aTyr Pharma Announces Research Collaboration With Global Biotherapeutics Leader CSL Behring6 March 2019
Glenmark Pharmaceuticals Announces Appointment of Alessandro Riva as CEO of its New Innovation Company5 March 2019
Numab Announces Entry into a License Agreement With Intarcia for Anti-Inflammatory ND0165 March 2019
Xenetic Biosciences, Inc. Announces Agreement to Acquire Innovative CAR T Technology Platform4 March 2019
Adagene Announces a Platform Evaluation of the Dynamic Precision Library with Celgene Corporation2 March 2019
MaxCyte Announces Multi-Drug Clinical & Commercial Agreement with Kite, a Gilead Company28 February 2019
Abpro and NJCTTQ Enter Into Partnership for Development of Multiple Novel Bispecific Antibodies28 February 2019
Sarepta Exercises Option to Acquire Myonexus Therapeutics27 February 2019
Selexis SA and Turgut Pharmaceuticals Expand Biosimilar Development Relationship by Signing Two Commercial License AgreementsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports